HEALTHSTORY 525· AUGUST 11, 2026

FDA Rejects ITM's Cancer Drug on Manufacturing Grounds, Blocking Novartis Rival

A manufacturing problem flagged by U.S. regulators has halted a radiopharmaceutical, a cancer therapy that works by delivering radioactive isotopes directly to tumor cells. The drug's maker, ITM Isotope Technologies Munich SE, had already…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 524An investor exits an industrial stock for an AI position after a weak quarter NEXT STORY 526 →Frida moves into kids' personal care, entering a market it calls largely untapped

Keep reading

More from the desk.

21HEALTH

Sanfilippo syndrome gets its first gene therapy approval after more than a decade of research

A rare childhood disease called Sanfilippo syndrome now has an approved gene therapy, the first one in the disease's history. Gene therapy, in plain terms, is a treatment that introduces corrected genetic material into a patient's cells to…

health1 MIN

33HEALTH

A rare genetic variant raises lung cancer risk 25-fold in people who have never smoked

Researchers have identified a rare genetic variant tied to a 25-fold increase in lung cancer odds among people who have never smoked, according to a study published Thursday in the journal Science. A genetic variant is a small, inherited…

health2 MIN

62HEALTH

Pennsylvania records fourth measles death, an 18-year-old from Mifflin County

Pennsylvania has now reported a fourth death connected to measles. The latest was an 18-year-old resident of Mifflin County, in the center of the state, who died from acute disseminated encephalomyelitis, a rare and severe neurological…

health1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk